View ValuationKangnam Jevisco 将来の成長Future 基準チェック /06現在、 Kangnam Jeviscoの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長51.7%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBuy Or Sell Opportunity • Mar 11Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 20% to ₩15,370. The fair value is estimated to be ₩12,643, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 2.5% over the last 3 years. Meanwhile, the company has become profitable.Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩14,860, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 51% over the past three years.お知らせ • Mar 05Kangnam Jevisco Co., Ltd, Annual General Meeting, Mar 26, 2026Kangnam Jevisco Co., Ltd, Annual General Meeting, Mar 26, 2026, at 09:00 Tokyo Standard Time. Location: conference room, 639, jungang-daero, busanjin-gu, busan South Koreaお知らせ • Feb 13Kangnam Jevisco Co., Ltd announces Annual dividendKangnam Jevisco Co. Ltd. announced Annual dividend of KRW 250.0000 per share, ex-date on February 26, 2026 and record date on February 27, 2026.分析記事 • Jan 19What Kangnam Jevisco Co., Ltd's (KRX:000860) 32% Share Price Gain Is Not Telling YouKangnam Jevisco Co., Ltd ( KRX:000860 ) shares have continued their recent momentum with a 32% gain in the last month...分析記事 • Jan 08Kangnam Jevisco (KRX:000860) Is Doing The Right Things To Multiply Its Share PriceDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Buy Or Sell Opportunity • Jan 08Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 25% to ₩14,970. The fair value is estimated to be ₩12,063, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 2.5% over the last 3 years. Meanwhile, the company has become profitable.分析記事 • Nov 12We Think Kangnam Jevisco (KRX:000860) Can Stay On Top Of Its DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...New Risk • May 23New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.5% Last year net profit margin: 3.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 23% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (1.5% net profit margin).Board Change • Apr 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Chairperson Ye-Jung Lim was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.New Risk • Mar 31New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩146.6b (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩146.6b market cap, or US$99.5m).Reported Earnings • Mar 22Full year 2024 earnings released: EPS: ₩2,039 (vs ₩2,541 in FY 2023)Full year 2024 results: EPS: ₩2,039 (down from ₩2,541 in FY 2023). Revenue: ₩643.1b (flat on FY 2023). Net income: ₩13.3b (down 20% from FY 2023). Profit margin: 2.1% (down from 2.6% in FY 2023). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.お知らせ • Mar 07+ 1 more updateKangnam Jevisco Co., Ltd announces Annual dividendKangnam Jevisco Co., Ltd announced Annual dividend of KRW 500.0000 per share, ex-date on December 27, 2024 and record date on December 31, 2024.Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩26,700, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years.Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩29.00 (vs ₩211 in 3Q 2023)Third quarter 2024 results: EPS: ₩29.00 (down from ₩211 in 3Q 2023). Revenue: ₩153.6b (down 3.3% from 3Q 2023). Net income: ₩188.8m (down 86% from 3Q 2023). Profit margin: 0.1% (down from 0.9% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.分析記事 • Mar 22Not Many Are Piling Into Kangnam Jevisco Co., Ltd (KRX:000860) Just YetWhen you see that almost half of the companies in the Chemicals industry in Korea have price-to-sales ratios (or "P/S...Upcoming Dividend • Dec 20Upcoming dividend of ₩500 per share at 2.4% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 29 April 2024. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).New Risk • Oct 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩131.6b (US$97.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (92% cash payout ratio). Large one-off items impacting financial results. Market cap is less than US$100m (₩131.6b market cap, or US$97.8m).New Risk • Aug 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.9b (US$99.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 128% Paying a dividend despite having no free cash flows. Earnings have declined by 15% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩132.9b market cap, or US$99.3m).Reported Earnings • May 20First quarter 2023 earnings released: ₩75.00 loss per share (vs ₩487 profit in 1Q 2022)First quarter 2023 results: ₩75.00 loss per share (down from ₩487 profit in 1Q 2022). Revenue: ₩149.4b (down 8.9% from 1Q 2022). Net loss: ₩486.2m (down 115% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩23,700, the stock trades at a trailing P/E ratio of 24.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years.Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩26,150, the stock trades at a trailing P/E ratio of 27.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past three years.Reported Earnings • Mar 24Full year 2022 earnings released: EPS: ₩952 (vs ₩6,948 in FY 2021)Full year 2022 results: EPS: ₩952 (down from ₩6,948 in FY 2021). Revenue: ₩673.2b (up 14% from FY 2021). Net income: ₩6.19b (down 86% from FY 2021). Profit margin: 0.9% (down from 7.6% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.Upcoming Dividend • Dec 21Upcoming dividend of ₩500 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 28 April 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (2.4%).Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Chairperson Ye-Jung Lim was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Chairperson Ye-Jung Lim was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Upcoming Dividend • Dec 22Upcoming dividend of ₩500 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 3.6% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).分析記事 • Apr 30Does Kangnam Jevisco (KRX:000860) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • Apr 12Is Kangnam Jevisco Co., Ltd (KRX:000860) A Smart Choice For Dividend Investors?Today we'll take a closer look at Kangnam Jevisco Co., Ltd ( KRX:000860 ) from a dividend investor's perspective...Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improved over the past weekAfter last week's 23% share price gain to ₩30,350, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years.分析記事 • Mar 26Returns On Capital At Kangnam Jevisco (KRX:000860) Paint A Concerning PictureIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...Reported Earnings • Mar 19Full year 2020 earnings released: EPS ₩3,583 (vs ₩2,250 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩340.8b (up 2.5% from FY 2019). Net income: ₩23.3b (up 59% from FY 2019). Profit margin: 6.8% (up from 4.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.分析記事 • Mar 08Here's What Kangnam Jevisco Co., Ltd's (KRX:000860) Shareholder Ownership Structure Looks LikeThe big shareholder groups in Kangnam Jevisco Co., Ltd ( KRX:000860 ) have power over the company. Institutions will...お知らせ • Mar 05Kangnam Jevisco Co., Ltd, Annual General Meeting, Mar 25, 2021Kangnam Jevisco Co., Ltd, Annual General Meeting, Mar 25, 2021, at 09:00 Korea Standard Time.Is New 90 Day High Low • Mar 02New 90-day high: ₩23,100The company is up 23% from its price of ₩18,800 on 02 December 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.分析記事 • Feb 15Kangnam Jevisco's (KRX:000860) Shareholders Are Down 36% On Their SharesKangnam Jevisco Co., Ltd ( KRX:000860 ) shareholders should be happy to see the share price up 23% in the last quarter...分析記事 • Jan 28Health Check: How Prudently Does Kangnam Jevisco (KRX:000860) Use Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Is New 90 Day High Low • Jan 21New 90-day high: ₩23,000The company is up 43% from its price of ₩16,050 on 23 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 39% over the same period.分析記事 • Jan 11Here's Why We Don't Think Kangnam Jevisco's (KRX:000860) Statutory Earnings Reflect Its Underlying Earnings PotentialStatistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. That said, the...分析記事 • Dec 24Only Four Days Left To Cash In On Kangnam Jevisco's (KRX:000860) DividendKangnam Jevisco Co., Ltd ( KRX:000860 ) stock is about to trade ex-dividend in four days. Ex-dividend means that...Upcoming Dividend • Dec 22Upcoming Dividend of ₩500 Per ShareWill be paid on the 24th of April to those who are registered shareholders by the 29th of December. The trailing yield of 2.4% is below the top quartile of South Korean dividend payers (2.6%), but it is higher than industry peers (0.9%).Is New 90 Day High Low • Dec 09New 90-day high: ₩19,100The company is up 19% from its price of ₩16,050 on 10 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period.分析記事 • Dec 07Is Kangnam Jevisco Co., Ltd. (KRX:000860) An Attractive Dividend Stock?Dividend paying stocks like Kangnam Jevisco Co., Ltd. ( KRX:000860 ) tend to be popular with investors, and for good...分析記事 • Nov 20What Percentage Of Kangnam Jevisco Co., Ltd. (KRX:000860) Shares Do Insiders Own?The big shareholder groups in Kangnam Jevisco Co., Ltd. (KRX:000860) have power over the company. Generally speaking...Is New 90 Day High Low • Nov 06New 90-day high: ₩17,100The company is up 13% from its price of ₩15,200 on 07 August 2020. The South Korean market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Kangnam Jevisco は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測KOSE:A000860 - アナリストの将来予測と過去の財務データ ( )KRW Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026604,465-4,0011,74238,389N/A12/31/2025598,553-2,68810,60138,631N/A9/30/2025613,2615,90923,43949,547N/A6/30/2025619,4386,4349,58536,342N/A3/31/2025635,2009,55219,64743,182N/A12/31/2024643,13713,25221,12247,172N/A9/30/2024639,45218,54115,85446,037N/A6/30/2024644,73419,72124,05167,326N/A3/31/2024638,38219,61114,26358,765N/A12/31/2023638,78916,51620,08665,767N/A9/30/2023646,8448,49016,34161,858N/A6/30/2023646,3575,3123,52944,315N/A3/31/2023658,6342,536-8,44639,788N/A12/31/2022673,1666,187-45,80414,382N/A9/30/2022673,423-30,820-61,5243,470N/A6/30/2022663,454-31,276-90,467-8,137N/A3/31/2022646,850-32,24427,566108,109N/A12/31/2021590,98445,165-75,198-1,789N/A9/30/2021519,10991,053-65,3601,831N/A6/30/2021454,77998,202-20,10417,720N/A3/31/2021370,642102,091-120,163-90,936N/A12/31/2020340,80723,2878,60430,541N/A9/30/2020330,49015,9938,14426,853N/A6/30/2020325,74413,017-7,36711,792N/A3/31/2020334,45012,726-9,95911,108N/A12/31/2019332,53914,623N/A11,189N/A9/30/2019330,55312,377N/A6,119N/A6/30/2019329,23137,899N/A13,686N/A3/31/2019318,67039,007N/A13,816N/A12/31/2018307,02138,625N/A10,276N/A9/30/2018295,81441,451N/A13,972N/A6/30/2018294,65018,154N/A10,691N/A3/31/2018297,67220,222N/A14,405N/A12/31/2017300,02523,187N/A25,390N/A9/30/2017271,50526,797N/A24,339N/A6/30/2017276,68731,408N/A27,726N/A3/31/2017283,18232,948N/A28,361N/A12/31/2016290,28634,680N/A25,596N/A9/30/2016285,65738,257N/A26,099N/A6/30/2016287,46538,390N/A25,944N/A3/31/2016291,04039,282N/A30,508N/A12/31/2015293,87340,256N/A28,746N/A9/30/2015302,09937,467N/A28,769N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: A000860の予測収益成長が 貯蓄率 ( 3.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: A000860の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: A000860の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: A000860の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: A000860の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A000860の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/12 20:15終値2026/08/12 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Kangnam Jevisco Co., Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Buy Or Sell Opportunity • Mar 11Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 20% to ₩15,370. The fair value is estimated to be ₩12,643, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 2.5% over the last 3 years. Meanwhile, the company has become profitable.
Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩14,860, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 51% over the past three years.
お知らせ • Mar 05Kangnam Jevisco Co., Ltd, Annual General Meeting, Mar 26, 2026Kangnam Jevisco Co., Ltd, Annual General Meeting, Mar 26, 2026, at 09:00 Tokyo Standard Time. Location: conference room, 639, jungang-daero, busanjin-gu, busan South Korea
お知らせ • Feb 13Kangnam Jevisco Co., Ltd announces Annual dividendKangnam Jevisco Co. Ltd. announced Annual dividend of KRW 250.0000 per share, ex-date on February 26, 2026 and record date on February 27, 2026.
分析記事 • Jan 19What Kangnam Jevisco Co., Ltd's (KRX:000860) 32% Share Price Gain Is Not Telling YouKangnam Jevisco Co., Ltd ( KRX:000860 ) shares have continued their recent momentum with a 32% gain in the last month...
分析記事 • Jan 08Kangnam Jevisco (KRX:000860) Is Doing The Right Things To Multiply Its Share PriceDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
Buy Or Sell Opportunity • Jan 08Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 25% to ₩14,970. The fair value is estimated to be ₩12,063, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 2.5% over the last 3 years. Meanwhile, the company has become profitable.
分析記事 • Nov 12We Think Kangnam Jevisco (KRX:000860) Can Stay On Top Of Its DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
New Risk • May 23New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.5% Last year net profit margin: 3.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 23% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (1.5% net profit margin).
Board Change • Apr 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Chairperson Ye-Jung Lim was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
New Risk • Mar 31New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩146.6b (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩146.6b market cap, or US$99.5m).
Reported Earnings • Mar 22Full year 2024 earnings released: EPS: ₩2,039 (vs ₩2,541 in FY 2023)Full year 2024 results: EPS: ₩2,039 (down from ₩2,541 in FY 2023). Revenue: ₩643.1b (flat on FY 2023). Net income: ₩13.3b (down 20% from FY 2023). Profit margin: 2.1% (down from 2.6% in FY 2023). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
お知らせ • Mar 07+ 1 more updateKangnam Jevisco Co., Ltd announces Annual dividendKangnam Jevisco Co., Ltd announced Annual dividend of KRW 500.0000 per share, ex-date on December 27, 2024 and record date on December 31, 2024.
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩26,700, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years.
Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩29.00 (vs ₩211 in 3Q 2023)Third quarter 2024 results: EPS: ₩29.00 (down from ₩211 in 3Q 2023). Revenue: ₩153.6b (down 3.3% from 3Q 2023). Net income: ₩188.8m (down 86% from 3Q 2023). Profit margin: 0.1% (down from 0.9% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
分析記事 • Mar 22Not Many Are Piling Into Kangnam Jevisco Co., Ltd (KRX:000860) Just YetWhen you see that almost half of the companies in the Chemicals industry in Korea have price-to-sales ratios (or "P/S...
Upcoming Dividend • Dec 20Upcoming dividend of ₩500 per share at 2.4% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 29 April 2024. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).
New Risk • Oct 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩131.6b (US$97.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (92% cash payout ratio). Large one-off items impacting financial results. Market cap is less than US$100m (₩131.6b market cap, or US$97.8m).
New Risk • Aug 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.9b (US$99.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 128% Paying a dividend despite having no free cash flows. Earnings have declined by 15% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩132.9b market cap, or US$99.3m).
Reported Earnings • May 20First quarter 2023 earnings released: ₩75.00 loss per share (vs ₩487 profit in 1Q 2022)First quarter 2023 results: ₩75.00 loss per share (down from ₩487 profit in 1Q 2022). Revenue: ₩149.4b (down 8.9% from 1Q 2022). Net loss: ₩486.2m (down 115% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩23,700, the stock trades at a trailing P/E ratio of 24.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years.
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩26,150, the stock trades at a trailing P/E ratio of 27.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past three years.
Reported Earnings • Mar 24Full year 2022 earnings released: EPS: ₩952 (vs ₩6,948 in FY 2021)Full year 2022 results: EPS: ₩952 (down from ₩6,948 in FY 2021). Revenue: ₩673.2b (up 14% from FY 2021). Net income: ₩6.19b (down 86% from FY 2021). Profit margin: 0.9% (down from 7.6% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.
Upcoming Dividend • Dec 21Upcoming dividend of ₩500 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 28 April 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (2.4%).
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Chairperson Ye-Jung Lim was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Chairperson Ye-Jung Lim was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Upcoming Dividend • Dec 22Upcoming dividend of ₩500 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 3.6% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).
分析記事 • Apr 30Does Kangnam Jevisco (KRX:000860) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Apr 12Is Kangnam Jevisco Co., Ltd (KRX:000860) A Smart Choice For Dividend Investors?Today we'll take a closer look at Kangnam Jevisco Co., Ltd ( KRX:000860 ) from a dividend investor's perspective...
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment improved over the past weekAfter last week's 23% share price gain to ₩30,350, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years.
分析記事 • Mar 26Returns On Capital At Kangnam Jevisco (KRX:000860) Paint A Concerning PictureIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...
Reported Earnings • Mar 19Full year 2020 earnings released: EPS ₩3,583 (vs ₩2,250 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩340.8b (up 2.5% from FY 2019). Net income: ₩23.3b (up 59% from FY 2019). Profit margin: 6.8% (up from 4.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
分析記事 • Mar 08Here's What Kangnam Jevisco Co., Ltd's (KRX:000860) Shareholder Ownership Structure Looks LikeThe big shareholder groups in Kangnam Jevisco Co., Ltd ( KRX:000860 ) have power over the company. Institutions will...
お知らせ • Mar 05Kangnam Jevisco Co., Ltd, Annual General Meeting, Mar 25, 2021Kangnam Jevisco Co., Ltd, Annual General Meeting, Mar 25, 2021, at 09:00 Korea Standard Time.
Is New 90 Day High Low • Mar 02New 90-day high: ₩23,100The company is up 23% from its price of ₩18,800 on 02 December 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.
分析記事 • Feb 15Kangnam Jevisco's (KRX:000860) Shareholders Are Down 36% On Their SharesKangnam Jevisco Co., Ltd ( KRX:000860 ) shareholders should be happy to see the share price up 23% in the last quarter...
分析記事 • Jan 28Health Check: How Prudently Does Kangnam Jevisco (KRX:000860) Use Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Is New 90 Day High Low • Jan 21New 90-day high: ₩23,000The company is up 43% from its price of ₩16,050 on 23 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 39% over the same period.
分析記事 • Jan 11Here's Why We Don't Think Kangnam Jevisco's (KRX:000860) Statutory Earnings Reflect Its Underlying Earnings PotentialStatistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. That said, the...
分析記事 • Dec 24Only Four Days Left To Cash In On Kangnam Jevisco's (KRX:000860) DividendKangnam Jevisco Co., Ltd ( KRX:000860 ) stock is about to trade ex-dividend in four days. Ex-dividend means that...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩500 Per ShareWill be paid on the 24th of April to those who are registered shareholders by the 29th of December. The trailing yield of 2.4% is below the top quartile of South Korean dividend payers (2.6%), but it is higher than industry peers (0.9%).
Is New 90 Day High Low • Dec 09New 90-day high: ₩19,100The company is up 19% from its price of ₩16,050 on 10 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period.
分析記事 • Dec 07Is Kangnam Jevisco Co., Ltd. (KRX:000860) An Attractive Dividend Stock?Dividend paying stocks like Kangnam Jevisco Co., Ltd. ( KRX:000860 ) tend to be popular with investors, and for good...
分析記事 • Nov 20What Percentage Of Kangnam Jevisco Co., Ltd. (KRX:000860) Shares Do Insiders Own?The big shareholder groups in Kangnam Jevisco Co., Ltd. (KRX:000860) have power over the company. Generally speaking...
Is New 90 Day High Low • Nov 06New 90-day high: ₩17,100The company is up 13% from its price of ₩15,200 on 07 August 2020. The South Korean market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period.